The new report “Europe
POCT Device Market” is expected to reach USD 11,682.54 billion by 2024 from
USD 6,051.05 billion in 2016, at a CAGR of 8.6% in the forecast period 2017 to
2024. The new market report contains data for historic years 2015, the base
year of calculation is 2016 and the forecast period is 2017 to 2024.
Europe
Point-of-care Testing (POCT) Market By Product (Blood Glucose Testing Kits,
Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol
Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers,
Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits,
Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation
Testing Kits, & Others),By Prescription Mode (Prescription Based Testing
& Over-The-Counter Testing),By Distribution Channel (Direct Tenders &
Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, &
Research Laboratory), By Country (Germany, United Kingdom, France, Spain,
Italy, Russia, Turkey, Belgium, Nether lands, Switzerland, Rest of Europe) –
Trends and Forecast to 2024
Ask for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=europe-poct-device-market
The major factors driving the
growth of this market are the rising scope of POCT devices, advancement in
technology, increasing incidence of chronic diseases, rising demand for
self-testing point-of-care testing devices, decentralized laboratory testing,
and technological advancements like microfluidic lab on a chip technology.
These factors increase the demand for devices such as blood glucose meter, CRP,
HBA1C, Homocystein. On the other hand, high costsare regulatory hurdles that
may hinder the growth of the market.
Market
Segmentation: Europe POCT Device Market
The Europe
POCT device market is segmented on the basis of product type, prescription
mode, distribution channel, end userand geography. The Europe POCT device
market is segmented into twelve types, namely blood glucose testing kits,
cardio metabolic monitoring kits, infectious disease testing kits, cholesterol
testing kits, pregnancy and fertility tests kits, tumor/cancer markers,
urinalysis testing kits, cholesterol test strips, hematology testing kits,
drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing
kits, and others.
Cardiometabolic monitoring kits
are further segmented into cardiac markers, blood gas/electrolytes testing
kits, HbA1c testing kits, and lipids testing. Also, infectious disease testing
kits are further segmented into influenza testing kits, HIV testing kits,
hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical
diseases testing kits, healthcare-associated infections), and respiratory
infections testing kit.
On the basis of prescription mode,
the Europe point-of-care testing market is segmented into prescription based
testing and over-the-counter (OTC) testing.
On the basis of distribution
channel, the Europe point-of-care testing market is segmented into direct
tenders and retail.
Inquiry
before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-poct-device-market
On the basis of end users, the
Europe point-of-care testing market is segmented into hospital, clinics,
ambulatory care, home healthcare, and research laboratory. Hospital segment is
further categorized into emergency department critical-care unit, general ward,
and others (intensive care unit, neo-natal).
Based on geography, the market is
segmented into11 geographical regions, such as Germany, France, U.K., Italy,
Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and rest of Europe.
Key
Drivers: Europe POCT Device Market
Some of the major factors driving
the market for rising scope of POCT devices, advancement in technology,
increasing incidence of chronic diseases, rising demand for self-testing
point-of-care testing devices, decentralized laboratory testing, and
technological advancements like microfluidic lab on a chip technology. These
factors increase the demand for devices such as blood glucose meter, CRP,
HBA1C, Homocystein.
Key
Points: Europe POCT Device Market
Some of the major players
operating in the Europe POCT Device
Market are Abbott Laboratories, Inc. (U.S.), Alere Inc. (U.S.), roche
Diagnostics Limited (Switzerland), Siemens AG (Germany), Becton, Dickinson and
Company (U.S.), Johnson & Johnson Services Inc. (U.S.), PTS Diagnostics
(U.S.), Instrumentation Laboratory (U.S.), Nova Biomedical (U.S.), Beckman
Coulter, Inc. (U.S.) and others.
The Europe point-of-care testing
market report contains an in-depth profiling of the key market players, along
with the recent developments (new product developments, partnerships,
agreements, collaborations, and joint ventures) and strategies adopted by them
to sustain and strengthen their position in the market. For instance, in 2016,
Health care giant Abbott Laboratories (U.S.) has acquiredAlere Inc. (U.S.), a
diagnostics-testing company for USD 5.8
billion. The intent was to get access over Alere’s portfolio that would provide
a quick diagnoses that would perform speedy test as well as can save the time
and cost.
Read more about the Europe POCT Device
Market Visit @ http://databridgemarketresearch.com/reports/europe-poct-device-market/
Related Report
Global
Blood Culture Test Market – Industry Trends and Forecast to 2024
Global Blood Culture
Test Market by Product Type, End User, Geography (North America, Europe, APAC,
South America, MEA)–Industry Trends and Forecast to 2024
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Vishal
Dixit
Data
Bridge Market Research
Tel:
+1-888-387-2818